Gangliosides in the repair of brain cholinergic neurons

• Autorzy: Oderfeld-Nowak B. , Casamenti F. , Pepeu G.
• Języki publikacji: EN

Słowa kluczowe

EN

brain; cholinergic neuron; ganglioside; neuron

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 1993
• Tom: 40
• Numer: 3
• Opis fizyczny: p.395-404,fig.

Twórcy

autor

Oderfeld-Nowak B.

• Nencki Institute of Experimental Biology, Pasteura 3, 02-093 Warszawa, Poland

autor

Casamenti F.

autor

Pepeu G.

Bibliografia

• 1. Fibiger, H.C. (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci. 14,220 - 223.
• 2. Perry, E.K., Johnson, M., Kerwin, J.M., Piggot, M.A., Court, J.A., Shaw, P.J., Ince, P.G., Brown, A. & Perry, R.H. (1992) Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol. Aging 13,393 - 400.
• 3. Traub, M. & Freedman, S.B. (1992) The impli­cation of current therapeutic approaches for the cholinergic hypothesis of dementia. Dementia 3, 189 -192.
• 4. Pepeu, G., Casamenti, F., Marconcini-Pepeu, I. & Scali, C. (1993) The brain cholinergic system in ageing mammals. J. Reprod. Fert. (Suppl.) 46, 155-162.
• 5. Kumar, V. & Calache, M. (1991) Treatment of Alzheimer's disease with cholinergic drugs. Int. J. Clin. Pharm. 29,23 -37.
• 6. Lapchak, P.A. (1992) Therapeutic potential for nerve growth factor in Alzheimer's disease: insights from pharmacological studies using lesioned central cholinergic neurons. Rev. Neurosci. 3,109 -119.
• 7. Vantini, G. & Skaper, S.D. (1992) Neurotrophic factors: from physiology to pharmacology? Pharmacol. Res. 26,1 -15.
• 8. Oderfeld-Nowak, B., Wôjcik, M., Ulas, J. & Potempska, A. (1981) Effect of chronic ganglio­side administration on recovery processes in rat hippocampus after brain lesions; in Gangliosides in Neurological and Neuromuscular Function (Rapport, M. & Gorio, A., eds.) pp. 197 - 209, Raven Press, New York.
• 9. Wôjcik, M., Ulas, J. & Oderfeld-Nowak, B. (1982) The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippo­campus of the rat after septal lesions. Neuro­science 7,495 - 499.
• 10. Cuello, A.C. (1990) Glycosphingolipids that can regulate nerve growth and repair. Adv. Pharma­col. 21,1-50.
• 11. Ledeen, R.W. (1985) Gangliosides of the neuron. Trends Neurosci. 8,169 -174.
• 12. Karpiak, S., Mahadik, S.P. & Wakade, C.G. (1990) Ganglioside reduction of ischemic injury. Crit. Rev. Neurobiol. 5,221 - 237.
• 13. Offano, G., Benvegnu, D., Bonetti, A.C., Facci, L., Leon, A., Orlando, P., Ghidoni, R. & Tettamanti, G. (1980) Interactions of GM1 ganglioside with crude rat brain neuronal membranes. J. Neurochem. 35,861 - 866.
• 14. Ogura, K. & Handa, S. (1988) Metabolism of exogenous gangliosides GM1 and chemically modified GM1 in mice. J. Biochem. (Tokyo) 104, 87-92.
• 15. Ghidoni, R., Fiorilli, A., Trinchera, M., Venerando, B., Chigorno, V. & Tettamanti, G. (1989) Uptake, cell penetration and metabolic processing of exogenously administered GM1 ganglioside in rat brain. Neurochem. Int. 15,455 -465.
• 16. Manev, H., Favaron, M., Vicini, S. & Guidotti, A. (1990) Ganglioside-mediated protection from glutamate-induced neuronal death. Acta Neurobiol. Exp. 50,475 - 488.
• 17. Pepeu, G., Oderfeld-Nowak, B. & Casamenti, F. (1993) CNS pharmacology of gangliosides. Prog. Brain Res. (in press).
• 18. Oderfeld-Nowak, B., Skup, M., Ulas, J., Jezierska, M., Gradkowska, M., Zaremba, M. (1984) Effect of GM1 ganglioside treatment on postlesion responses of cholinergic neurons in rat hippocampus after various partial deafferen- tations. }. Neurosci. Res. 12,409 - 420.
• 19. Gradkowska, M., Skup, M., Kiedrowski, L., Calzolari, S. & Oderfeld-Nowak, B. (1986) The effect of GM1 ganglioside on cholinergic and serotoninergic systems in the rat hippocampus following partial denervation is dependent on the degree of fiber degeneration. Brain Res. 375, 417-422.
• 20. Skup, M., Gradkowska, M., Ulas, J. & Oderfeld-Nowak, B. (1987) Analysis of the time course of GM1 ganglioside effect on changes in choline acetyltransferase activity in partially denervated rat hippocampus. Acta Neurobiol. Exp. 47,199-211.
• 21. Oderfeld-Nowak, B., Grqdkowska, M., Zaremba, M. & Kiedrowski, L. (1988) Protection against secondary degeneration of nerve terminals in target structure - a possible mechanism to account for early beneficial effects of ganglioside treatment in injured brain; in New Trends in Ganglioside Research: Neurochemical and Neurodegenerative Aspects (Ledeen, R.W., Hogan, E.L., Tettamanti, G., Yates, A. J., Yu, R.K., eds.) pp. 567 - 577, Fidia Res. Ser. 14, Liviana Press.
• 22. Cannella, M.S., Oderfeld-Nowak, B., Grqdko- wska, M., Skup, M., Garofalo, L., Cuello, A.C. & Ledeen, R.W. (1990) Derivatives of ganglioside GM1 as neuronotrophic agents: comparison of in vivo and in vitro effects. Brain Res. 513, 286 - 294.
• 23. Ledeen, R.W., Wu, G., Cannella, M.S., Oderfeld- -Nowak, B. & Cuello, A.C. (1990) Gangliosides as neurotrophic agents: studies on mechanisms of actions. Acta Neurobiol. Exp. 50,430.
• 24. Pedata, F., Giovannelli, L. & Pepeu, G. (1984) GM1 ganglioside facilitates the recovery of high affinity choline uptake in the cerebral cortex of rats with a lesion of the nucleus basalis magnocellularis. J. Neurosci. Res. 12,421 - 427.
• 25. Casamenti, F., Bracco, L., Bartolini, L. & Pepeu, G. (1985) Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei. Brain Res. 338,45 - 52.
• 26. Casamenti, F., Di Patre, P.L., Milan, F., Petrelli, L. & Pepeu, G. (1989) Effects of nerve growth factor and GM1 ganglioside on the number of cholinergic neurons in rats with unilateral lesion of the nucleus basalis. Neurosci. Lett. 103, 87-91.
• 27. Di Patre, P.L., Abbomonti, A., Bartolini, L. & Pepeu, G. (1989) GM1 ganglioside counteracts cholinergic and behavioural deficits induced in the rat by intracerebral injection of vincristine. Eur. J. Pharmacol. 162,43 - 50.
• 28. Di Patre, P.L., Casamenti, F., Cenni, A. & Pepeu, G. (1989) Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. Brain Res. 480, 219 -224.
• 29. Casamenti, F., Milan, F. & Pepeu, G. (1990) Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1. Acta Neurobiol. Exp. 50,461-473.
• 30. Sofroniew, M.V., Pearson, R.C.A., Cuello, A.C., Tagari, P.C. & Stephens, PH. (1986) Parenterally administered GM1 ganglioside prevents retro­grade degeneration of cholinergic cells of the rat basal forebrain. Brain Res. 398,393 - 396.
• 31. Tuszynski, M.H., Armstrong, D.M. & Gage, F.H. (1990) Basal forebrain cell loss following fimbria fornix transection. Brain Res. 508,241 - 248.
• 32. Cuello, A.C., Stephens, P.H., Tagari, P.C. & Sofroniew, M.V., Pearson, R.C.A. (1986) Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1. Brain Res. 376, 373 - 377.
• 33. Cuello, A.C., Garofalo, L., Kenigsberg, R.L. & Maysinger, D. (1989) Ganglioside potentiate invivo and in vitro effects of nerve growth factor on central cholinergic neurons. Pmc. Natl. Acad. Sci. U.S.A. 86,2056 - 2060.
• 34. Elliott, P.J., Garofalo, L. & Cuello, A.C. (1989) Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity-effects of the monosialoganglioside GM1. Neuroscience 31,63 -76.
• 35. Maysinger, D., Herrera-Marschitz, M., Carlsson, A., Garofalo, L., Cuello, A.C. & Ungerstedt, U. (1988) Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: Effects of treatment with monosialoganglioside GM1. Brain Res. 461,355 - 360.
• 36. Maysinger, D., Garofalo, L., Jalsenjak, I. & Cuello, A.C. (1989) Effects of microcapsulated monosialoganglioside GM1 on cholinergic neurons. Brain Res. 496,165 - 172.
• 37. Pióro, E.P., Maysinger, D., Ervin, F.R., Desypris, G. & Cuello, A.C. (1993) Primate nucleus basalis of Meynert P 75NGFR containing cholinergic neurons are protected from retrograde degene­ration by the ganglioside GM1. Neuroscience 53, 49-56.
• 38. Emerich, D.F., Walsh, T.J. (1991) Ganglioside AGF2 prevents cognitive impairments and cholinergic cell loss following intraventricular colchicine. Exp. Neurol. 112,328 - 337.
• 39. Stephens, P.H., Tagari, T.C. & Cuello, A.C. (1988) Retrograde degeneration of basal forebrain cholinergic neurons after neurotoxin lesion of the neocortex: application of ganglioside GM1. Neurochem. Int. 12,475 - 481.
• 40. Stephens, P.H., Tagari, P.C., Garofalo, L., Maysinger, D., Protte, M. & Cuello, A.C. (1987) Neural plasticity of basal cholinergic neurons: Effects of gangliosides. Neurosci. Lett. 80,80 - 84.
• 41. Hadjiconstantinou, M., Karadshen, N.S., Rat­tan, A.K., Tejwani, G.A., Fitkin, J.G. & Neff, N.H. (1991) GM1 ganglioside enhances cholinergic parameters in the brain of senescent rats. Neuroscience 46,681 - 686.
• 42. Fusco, M., Oderfeld-Nowak, B., Vantini, G., Schiavo, N., Grądkowska, M., Zaremba, M. & Leon, A. (1989) Nerve growth factor affects uninjured, adult rat septohippocampal choli­nergic neurons. Neuroscience 33,47 - 52.
• 43. Tuszyński, M.H., Amaral, D.G. & Gage, F.H. (1990) Nerve growth factor infusion in the primate brain reduces lesion-induced choli­nergic neuronal degeneration. J. Neurosci. 10, 3604 - 3614.
• 44. Koliatsos, V.E., Clatterbuck, R.E., Nanta, H.J., Knusel, B., Burton, L.E., Hefti, F., Mobley, W.C. & Price, D.L. (1991) Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 30, 831-840.
• 45. Liberini, P., Pioro, E.P., Maysinger, D., Ervin, F.H. & Cuello, A.C. (1993) Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside-GMl treatment on primate nucleus basalis cholinergic neurons after neocortical infarction. Neuroscience 53,625 - 637.
• 46. Oderfeld-Nowak, B., Jeglinski, W., Skup, M., Skangiel-Kramska, J., Zaremba, M. & Koczyk, D. (1993) Differential effects of GM1 ganglioside treatment on glial fibrillary acidic protein content in the rat septum and hippocampus after partial interruption of their connections. J. Neurochem. 61,116-119.
• 47. Svennerholm, L., Gottfries, C.G., Bleunow, K., Freedman, P., Karlsson, J., Mannson, J.E., Toffano, G. & Wallin, A. (1990) Parenteral administration of GM1 ganglioside in Alzheimer patients. Acta Neurol. Scand. 81,48 - 53.
• 48. Geisler, F.H., Dorsey, F.C. & Coleman, W.P. (1991) Recovery of motor function after spinal cord injury - a randomized, placebo-controlled trial with GMl-ganglioside. New Engl. J. Med. 324,1829 -1838.